Cargando…

Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells

Induced pluripotent stem (iPS) cells are a type of artificial pluripotent stem cell induced by the epigenetic silencing of somatic cells by the Yamanaka factors. Advances in iPS cell reprogramming technology will allow aging or damaged cells to be replaced by a patient’s own rejuvenated cells. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Naomichi, Kato, Hidemasa, Tsuda, Hiromi, Sato, Yasunori, Muramatsu, Toshihiro, Iguchi, Atsushi, Nakajima, Hiroyuki, Yoshitake, Akihiro, Senbonmatsu, Takaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555779/ https://www.ncbi.nlm.nih.gov/pubmed/32942642 http://dx.doi.org/10.3390/ijms21186764

Ejemplares similares

Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
por: Dey, Dilip, et al.
Publicado: (2011)

Reprogramming resistant genes: in-depth comparison of gene expressions among iPS, ES, and somatic cells
por: Polouliakh, Natalia
Publicado: (2013)

Somatic Reprogramming—Above and Beyond Pluripotency
por: Meir, Yaa-Jyuhn James, et al.
Publicado: (2021)

Telomere Reprogramming and Maintenance in Porcine iPS Cells
por: Ji, Guangzhen, et al.
Publicado: (2013)

Premature Acute Myocardial Infarction in a Young Patient With Sitosterolemia
por: Yamada, Yoshihiro, et al.
Publicado: (2021)

Modulation of Pluripotency in the Porcine Embryo and iPS Cells
por: Rodríguez, Aida, et al.
Publicado: (2012)

Correction: Telomere Reprogramming and Maintenance in Porcine iPS Cells
por: Ji, Guangzhen, et al.
Publicado: (2013)

Pramef12 enhances reprogramming into naïve iPS cells
por: Haraguchi, Daiki, et al.
Publicado: (2022)

Relationship between Soluble (Pro)Renin Receptor and Renin Activity in Patients with Severe Heart Failure
por: Ikeda, Yoshifumi, et al.
Publicado: (2020)

Analysis of the stability of 70 housekeeping genes during iPS reprogramming
por: Panina, Yulia, et al.
Publicado: (2020)

Concise Review: Are Stimulated Somatic Cells Truly Reprogrammed into an ES/iPS-Like Pluripotent State? Better Understanding by Ischemia-Induced Multipotent Stem Cells in a Mouse Model of Cerebral Infarction
por: Nakagomi, Takayuki, et al.
Publicado: (2015)

Reprogramming to Pluripotency Can Conceal Somatic Cell Chromosomal Instability
por: Hamada, Masakazu, et al.
Publicado: (2012)

Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate
por: Marthaler, Adele G., et al.
Publicado: (2013)

Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance
por: Ozmadenci, Duygu, et al.
Publicado: (2015)

Induced pluripotent stem (iPS) cells: an up-to-the-minute review
por: Lau, Frank, et al.
Publicado: (2009)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review
por: Malhotra, Neeraj
Publicado: (2016)

A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells
por: Goh, Pollyanna A., et al.
Publicado: (2013)

Technological Overview of iPS Induction from Human Adult Somatic Cells
por: Bayart, Emilie, et al.
Publicado: (2013)

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
por: Yilmazer, Açelya, et al.
Publicado: (2013)

Dynamically reorganized chromatin is the key for the reprogramming of somatic cells to pluripotent cells
por: Huang, Kaimeng, et al.
Publicado: (2015)

Sirt6 regulates efficiency of mouse somatic reprogramming and maintenance of pluripotency
por: Xu, Peng, et al.
Publicado: (2019)

Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells
por: Liu, Xinyu, et al.
Publicado: (2020)

An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
por: Di Stefano, Bruno, et al.
Publicado: (2010)

Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells
por: Biswas, Dhruba, et al.
Publicado: (2016)

Maxadilan Prevents Apoptosis in iPS Cells and Shows No Effects on the Pluripotent State or Karyotype
por: Zhao, Zhiyi, et al.
Publicado: (2012)

DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells
por: Liu, Kai, et al.
Publicado: (2017)

Beyond iPS!
Publicado: (2012)

PIWI Proteins Are Dispensable for Mouse Somatic Development and Reprogramming of Fibroblasts into Pluripotent Stem Cells
por: Cheng, Ee-Chun, et al.
Publicado: (2014)

Self-Renewal and Pluripotency Acquired through Somatic Reprogramming to Human Cancer Stem Cells
por: Nagata, Shogo, et al.
Publicado: (2012)

Transient Acquisition of Pluripotency During Somatic Cell Transdifferentiation with iPSC Reprogramming Factors
por: Maza, Itay, et al.
Publicado: (2015)

Promyelocytic Leukemia Protein Is an Essential Regulator of Stem Cell Pluripotency and Somatic Cell Reprogramming
por: Hadjimichael, Christiana, et al.
Publicado: (2017)

Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells
por: Kim, Young Mi, et al.
Publicado: (2017)

Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency
por: Bredenkamp, Nicholas, et al.
Publicado: (2019)

Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate
por: Wang, Aline Yen Ling
Publicado: (2021)

c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency
por: Prieto, Javier, et al.
Publicado: (2021)

Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming
por: Xi, Chenxiang, et al.
Publicado: (2022)

Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells
por: Yu, Yang, et al.
Publicado: (2015)

Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps
Publicado: (2018)

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells
por: Burramsetty, Arun Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jji65hmc5hssrkd3h242r1glh0